The FDA approved the Oncomine Dx Express Test for rapid identification of NSCLC patients eligible for Zegfrovy treatment. The test provides results in 24 hours, aiding timely therapeutic decisions and ...
Lung cancer remains a leading cause of cancer-related mortality worldwide, highlighting the urgent need for a nuanced understanding of its diagnosis and treatment options, especially in special ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results